Cdk2 Silencing via a DNA/PCL Electrospun Scaffold Suppresses Proliferation and Increases Death of Breast Cancer Cells

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Achille, Clément ^a   Sundaresh, Sowmya ^b   Chu, Benjamin ^c   Hadjiargyrou, Michael ^d  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b St Francis Hospital The Heart Center   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 2; ENHANCED GREEN FLUORESCENT PROTEIN; MESSENGER RNA; PLASMID DNA; POLYCAPROLACTONE; SHORT HAIRPIN RNA;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL CYCLE REGULATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DEGRADATION; ELECTROSPINNING; GENE EXPRESSION; GENE SILENCING; GROWTH INHIBITION; HUMAN; HUMAN CELL; INCUBATION TIME; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; NUCLEOTIDE SEQUENCE; PARTICLE SIZE; RNA INTERFERENCE; SCANNING ELECTRON MICROSCOPY;

BREAST NEOPLASMS; CELL DEATH; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE 2; DNA; FEMALE; GENE SILENCING; GENE TRANSFER TECHNIQUES; HUMANS; MCF-7 CELLS; PLASMIDS; POLYESTERS; RNA, SMALL INTERFERING; TISSUE SCAFFOLDS;

EID: 84871433579     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052356     Document Type: Article

References (43)

1. Pecot CV, Calin GA, Coleman RL, Lopez-Berestein G, Sood AK, (2011) RNA interference in the clinic: challenges and future directions. Nat Rev Cancer 11: 59-67.
2. Wu SY, McMillan NA, (2009) Lipidic systems for in vivo siRNA delivery. AAPS J 11: 639-652.
3. Li J, Huang L, (2010) Targeted delivery of RNAi therapeutics for cancer therapy. Nanomedicine 5: 1483-1486.
4. Smith MH, Lyon LA, (2012) Multifunctional Nanogels for siRNA Delivery. Acc Chem Res 45(7): 985-993.
5. Monaghan M, Pandit A, (2011) RNA interference therapy via functionalized scaffolds. Adv Drug Deliv Rev 63: 197-208.
6. Martins A, Araújo JV, Reis RL, Neves NM, (2007) Electrospun nanostructured scaffolds for tissue engineering applications. Nanomedicine 2: 929-942.
7. Hong JK, Madihally SV, (2011) Next generation of electrosprayed fibers for tissue regeneration. Tissue Eng Part B Rev 17: 125-142.
8. Hadjiargyrou M (2011) Incorporation of DNA into Electrospun Nanofibrous Scaffolds: Fundamental studies and DNA Delivery. In: Lin T, editor. Nanofibers-Production, Properties and Functional Applications. Vienna, Austria: INTECH. p. 383-400.
9. Hadjiargyrou M, Chiu JB, (2008) Enhanced composite electrospun nanofiber scaffolds for use in drug delivery. Expert Opin Drug Deliv 5: 1093-1106.
10. Chiu JB, Luu YK, Fang D, Hsiao BS, Chu B, et al. (2005) Electrospun Nanofibrous Scaffolds for Biomedical Applications. J Biomed Nanotech 1: 115-132.
11. Kim K, Luu YK, Chang C, Fang D, Hsiao BS, et al. (2004) Incorporation and controlled release of a hydrophilic antibiotic using poly(lactide-co-glycolide)-based electrospun nanofibrous scaffolds. J Control Release 98: 47-56.
12. Luu YK, Kim K, Hsiao BS, Chu B, Hadjiargyrou M, (2003) Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA-PEG block copolymers. J Control Release 43: 341-543.
13. Liang D, Luu YK, Kim K, Hsiao BS, Hadjiargyrou M, et al. (2005) In vitro non-viral gene delivery with nanofibrous scaffolds, Nucleic Acids Res. 33: e170.
14. Chu B, Liang D, Hadjiargyrou M, Hsiao BS, (2006) A new pathway for developing in-vitro nanostructured non-viral gene carriers. J Phys Condens Matter 18: S2513-S2525.
15. Chiu J, Liu C, Hsiao BS, Chu B, Hadjiargyrou M, (2007) Functionalization of Poly(L-lactide) (PLLA) Nanofibrous Scaffolds with Bioactive Collagen Molecules. J Biomed Mater Res A 83: 1117-1127.
16. Zhao X, Hadjiargyrou M, (2011) Induction of cell migration in vitro by an Electrospun PDGF-BB/PLGA/PEG-PLA Nanofibrous Scaffold. J Biomed Nanotech 7: 823-829.
17. Nie H, Wang CH, (2007) Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA. J Control Release 120: 111-121.
18. Sakai S, Yamada Y, Yamaguchi T, Ciach T, Kawakami K, (2009) Surface immobilization of poly(ethyleneimine) and plasmid DNA on electrospun poly(L-lactic acid) fibrous mats using a layer-by-layer approach for gene delivery. J Biomed Mater Res A 88: 281-287.
19. Yang DJ, Xiong CD, Govender T, Wang YZ, (2009) Preparation and drug-delivery potential of metronidazole-loaded PELA tri-block co-polymeric electrospun membranes. J Biomater Sci Polym Ed 20: 1321-1334.
20. Fan X, Ni S, Qi H, Wang X, Wang C, et al. (2010) Biodegradable microfibers deliver the antitumor drug temozolomide to glioma C6 cells in vitro. Pharmazie 65: 830-834.
21. Kim HS, Yoo HS, (2010) MMPs-responsive release of DNA from electrospun nanofibrous matrix for local gene therapy: in vitro and in vivo evaluation. J Control Release 145: 264-271.
22. Saraf A, Baggett LS, Raphael RM, Kasper FK, Mikos AG, (2010) Regulated non-viral gene delivery from coaxial electrospun fiber mesh scaffolds. J Control Release 143: 95-103.
23. Shen X, Yu D, Zhu L, Branford-White C, White K, et al. (2011) Electrospun diclofenac sodium loaded Eudragit® L 100-55 nanofibers for colon-targeted drug delivery. Int J Pharm 408: 200-207.
24. Yang Y, Li X, Cheng L, He S, Zou J, et al. (2011) Core-sheath structured fibers with pDNA polyplex loadings for the optimal release profile and transfection efficiency as potential tissue engineering scaffolds. Acta Biomater 7: 2533-2543.
25. Zhang J, Duan Y, Wei D, Wang L, Wang H, et al. (2011) Co-electrospun fibrous scaffold-adsorbed DNA for substrate-mediated gene delivery. J Biomed Mater Res A 96: 212-220.
26. Cao H, Jiang X, Chai C, Chew SY, (2010) RNA interference by nanofiber-based siRNA delivery system. J Control Release 144: 203-212.
27. Rujitanaroj PO, Wang YC, Wang J, Chew SY, (2011) Nanofiber-mediated controlled release of siRNA complexes for long term gene-silencing applications. Biomaterials 32: 5915-5923.
28. Gersch RP, Hadjiargyrou M, (2009) Mustn1 is expressed during chondrogenesis and is necessary for chondrocyte proliferation and differentiation in vitro. Bone 45: 330-338.
29. Liu C, Gersch RP, Hawke TJ, Hadjiargyrou M, (2010) Silencing of Mustn1 inhibits myogenic fusion and differentiation. Am J Physiol Cell Physiol 298: C1100-C1108.
30. Krebs MD, Jeon O, Alsberg E, (2009) Localized and sustained delivery of silencing RNA from macroscopic biopolymer hydrogels, J Am Chem Soc. 131: 9204-9206.
31. Singh A, Suri S, Roy K, (2009) In-situ crosslinking hydrogels for combinatorial delivery of chemokines and siRNA-DNA carrying microparticles to dendritic cells, Biomaterials. 30: 5187-5200.
32. San Juan A, Bala M, Hlawaty H, Portes P, Vranckx R, et al. (2009) Development of a functionalized polymer for stent coating in the arterial delivery of small interfering RNA. Biomacromolecules 10: 3074-3080.
33. Takahashi H, Wang Y, Grainger DW, (2010) Device-based local delivery of siRNA against mammalian target of rapamycin (mTOR) in a murine subcutaneous implant model to inhibit fibrous encapsulation. J Control Release 147: 400-407.
34. Han HD, Mora EM, Roh JW, Nishimura M, Lee SJ, et al. (2011) Chitosan hydrogel for localized gene silencing. Cancer Biol Ther 11: 839-845.
35. Dimitrova M, Affolter C, Meyer F, Nguyen I, Richard DG, et al. (2008) Sustained delivery of siRNAs targeting viral infection by cell-degradable multilayered polyelectrolyte films. Proc Natl Acad Sci USA 105: 16320-16325.
36. Zhang X, Kovtun A, Mendoza-Palomares C, Oulad-Abdelghani M, Fioretti F, et al. (2010) SiRNA-loaded multi-shell nanoparticles incorporated into a multilayered film as a reservoir for gene silencing. Biomaterials 31: 6013-6018.
37. Andersen MO, Nygaard JV, Burns JS, Raarup MK, Nyengaard JR, et al. (2010) siRNA nanoparticle functionalization of nanostructured scaffolds enables controlled multilineage differentiation of stem cells. Mol Ther 18: 2018-2027.
38. Tzeng SY, Yang PH, Grayson WL, Green JJ, (2011) Synthetic poly(ester amine) and poly(amido amine) nanoparticles for efficient DNA and siRNA delivery to human endothelial cells. Int J Nanomedicine 6: 3309-3322.
39. Rahman MA, Amin AR, Wang X, Zuckerman JE, Choi CH, et al. (2012) Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth. J Control Release 159: 384-392.
40. Viñas-Castells R, Holladay C, di Luca A, Díaz VM, Pandit A, (2009) Snail1 downregulation using small interfering RNA complexes delivered through collagen scaffolds. Bioconjug Chem 20: 2262-2269.
41. Holladay C, Keeney M, Greiser U, Murphy M, O'Brien T, et al. (2009) A matrix reservoir for improved control of non-viral gene delivery. J Control Release 136: 220-225.
42. Takanashi M, Oikawa K, Sudo K, Tanaka M, Fujita K, et al. (2009) Therapeutic silencing of an endogenous gene by siRNA cream in an arthritis model mouse. Gene Ther 16: 982-989.
43. Long XE, Gong ZH, Pan L, Zhong ZW, Le YP, et al. (2010) Suppression of CDK2 expression by siRNA induces cell cycle arrest and cell proliferation inhibition in human cancer cells. BMB Rep 43: 291-296.